Versigent Q3 Earnings Call Highlights
TD Cowen Maintains Buy on Versigent, Raises Price Target to $59
RBC Capital Maintains Outperform on Versigent, Lowers Price Target to $52
BNP Paribas Reiterates Outperform on Versigent, Lowers Price Target to $54
Versigent CFO to Participate in RBC Capital Markets Global Industrials Conference on November 17
Versigent PLC 2026 Q3 - Results - Earnings Call Presentation
Versigent (VGNT) Following Third Quarter Results Looks Cheap On Earnings And Cash Flow
Versigent PLC (VGNT) (Q3 2026) Earnings Call Highlights: Raised Cash Flow Outlook, $2. ...
Versigent PLC (VGNT) Q3 2026 Earnings Call Transcript
Versigent: Q3 Earnings Snapshot
Versigent Reports Third Quarter 2026 Results
Versigent Raises FY2026 Sales Guidance from $9.400B-$9.600B to $9.500B-$9.600B vs $9.516B Est
Versigent Q3 Adj. EPS $1.91 Beats $1.80 Estimate, Sales $2.450B Beat $2.422B Estimate
RBC Capital Maintains Outperform on Versigent, Raises Price Target to $53
Goldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58
Versigent Announces Third Quarter 2026 Earnings Call Details
Versigent Q2 2026 Earnings Call Transcript
Versigent (VGNT) Price Target Increased by 11.19% to 57.12
Why Versigent (VGNT) Stands to Benefit from Automotive Trends
Versigent (VGNT) Rallies Again With Valuation Still In Focus
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.